Product Information
ONDANSETRON HCL 4 MG/2 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1759 per ML under NDC 00641607825. Its NADAC has been published 607 times since Nov 28, 2013.
FDA first approved this application on Dec 26, 2006. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641607825
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077541FDA Approved
12/26/2006
TE Code
AP
On Market Since
12/26/2006
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has been published 607 times since Nov 28, 2013, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1759 per ML |
|---|---|
| All-time high | $0.4373 (May 14, 2014) |
| All-time low | $0.1702 (Aug 18, 2021) |
| 52-week high | $0.2112 |
| 52-week low | $0.1759 |
| Median price | $0.2168 |
| Average price | $0.2296 |
| Largest weekly change | +72.3% (Jun 22, 2016) |
| Weeks tracked | 607 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ondansetron market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 4 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 4 MG/2 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1759 per ML (NDC 00641607825), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 4 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has declined 39.8%. It has been tracked across 607 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 4 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has ranged from a low of $0.1702 (Aug 18, 2021) to a high of $0.4373 (May 14, 2014), with a median of $0.2168 per ML.
Are there cheaper alternatives to ONDANSETRON HCL 4 MG/2 ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON 40 MG/20 ML VIAL, is $0.1730 per ML — about 2% below ONDANSETRON HCL 4 MG/2 ML VIAL.
Who manufactures ONDANSETRON HCL 4 MG/2 ML VIAL?
ONDANSETRON HCL 4 MG/2 ML VIAL (NDC 00641607825) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.